位置:首页 > 蛋白库 > RGN_RAT
RGN_RAT
ID   RGN_RAT                 Reviewed;         299 AA.
AC   Q03336; Q63496; Q925W3; Q9QWP2;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 3.
DT   03-AUG-2022, entry version 147.
DE   RecName: Full=Regucalcin;
DE            Short=RC;
DE   AltName: Full=Gluconolactonase;
DE            Short=GNL;
DE            EC=3.1.1.17;
DE   AltName: Full=Senescence marker protein 30;
DE            Short=SMP-30;
GN   Name=Rgn; Synonyms=Smp30;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=1420310; DOI=10.1016/0167-4781(92)90164-u;
RA   Fujita T., Shirasawa T., Uchida K., Maruyama N.;
RT   "Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30)
RT   and its tissue distribution.";
RL   Biochim. Biophys. Acta 1132:297-305(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8348951; DOI=10.1016/0014-5793(93)80998-a;
RA   Shimokawa N., Yamaguchi M.;
RT   "Molecular cloning and sequencing of the cDNA coding for a calcium-binding
RT   protein regucalcin from rat liver.";
RL   FEBS Lett. 327:251-255(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Misawa H., Yamaguchi M.;
RT   "The gene family encoding the calcium-binding protein regucalcin.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-115.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8979263; DOI=10.1007/bf00229476;
RA   Yamaguchi M., Makino R., Shimokawa N.;
RT   "The 5' end sequences and exon organization in rat regucalcin gene.";
RL   Mol. Cell. Biochem. 165:145-150(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 117-299.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8569761; DOI=10.1007/bf01322338;
RA   Shimokawa N., Matsuda Y., Yamaguchi M.;
RT   "Genomic cloning and chromosomal assignment of rat regucalcin gene.";
RL   Mol. Cell. Biochem. 151:157-163(1995).
RN   [7]
RP   PROTEIN SEQUENCE OF 113-124, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=16585534; DOI=10.1073/pnas.0511225103;
RA   Kondo Y., Inai Y., Sato Y., Handa S., Kubo S., Shimokado K., Goto S.,
RA   Nishikimi M., Maruyama N., Ishigami A.;
RT   "Senescence marker protein 30 functions as gluconolactonase in L-ascorbic
RT   acid biosynthesis, and its knockout mice are prone to scurvy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5723-5728(2006).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8794449; DOI=10.1016/0047-6374(96)01711-3;
RA   Fujita T., Shirasawa T., Uchida K., Maruyama N.;
RT   "Gene regulation of senescence marker protein-30 (SMP30): coordinated up-
RT   regulation with tissue maturation and gradual down-regulation with aging.";
RL   Mech. Ageing Dev. 87:219-229(1996).
RN   [9]
RP   FUNCTION, AND COFACTOR.
RX   PubMed=15251439; DOI=10.1016/j.febslet.2004.06.028;
RA   Kondo Y., Ishigami A., Kubo S., Handa S., Gomi K., Hirokawa K.,
RA   Kajiyama N., Chiba T., Shimokado K., Maruyama N.;
RT   "Senescence marker protein-30 is a unique enzyme that hydrolyzes
RT   diisopropyl phosphorofluoridate in the liver.";
RL   FEBS Lett. 570:57-62(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Gluconolactonase with low activity towards other sugar
CC       lactones, including gulonolactone and galactonolactone. Catalyzes a key
CC       step in ascorbic acid (vitamin C) biosynthesis. Can also hydrolyze
CC       diisopropyl phosphorofluoridate and phenylacetate (in vitro). Calcium-
CC       binding protein. Modulates Ca(2+) signaling, and Ca(2+)-dependent
CC       cellular processes and enzyme activities. {ECO:0000269|PubMed:15251439,
CC       ECO:0000269|PubMed:16585534, ECO:0000269|PubMed:8794449}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucono-1,5-lactone + H2O = D-gluconate + H(+);
CC         Xref=Rhea:RHEA:10440, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16217, ChEBI:CHEBI:18391; EC=3.1.1.17;
CC         Evidence={ECO:0000269|PubMed:16585534};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Note=Binds 1 divalent metal cation per subunit. Most active with Zn(2+)
CC       and Mn(2+) ions. The physiological cofactor for gluconolactonase
CC       activity is most likely Ca(2+) or Mg(2+). Mg(2+), Mn(2+) and Co(2+) are
CC       equally efficient for the hydrolysis of diisopropyl
CC       phosphorofluoridate. {ECO:0000269|PubMed:15251439,
CC       ECO:0000269|PubMed:16585534};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.4 mM for gluconolactone {ECO:0000269|PubMed:16585534};
CC         Vmax=345 umol/min/mg enzyme {ECO:0000269|PubMed:16585534};
CC       pH dependence:
CC         Optimum pH is 6.4. {ECO:0000269|PubMed:16585534};
CC   -!- PATHWAY: Cofactor biosynthesis; L-ascorbate biosynthesis via UDP-alpha-
CC       D-glucuronate pathway; L-ascorbate from UDP-alpha-D-glucuronate: step
CC       3/4. {ECO:0000269|PubMed:16585534}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Detected in liver (at protein level). Hepatocytes
CC       and renal proximal tubular epithelium. {ECO:0000269|PubMed:1420310,
CC       ECO:0000269|PubMed:16585534, ECO:0000269|PubMed:8794449}.
CC   -!- DEVELOPMENTAL STAGE: In liver, the first peak of expression was found
CC       in 5-day-old neonates. Expression increases from day 7 and reaches a
CC       plateau at day 10. 3-6.5 moth-old adults express about a third the
CC       amount of neonates level. In kidney, expression increases from day 21
CC       and reaches a maximal level at day 35, remains high until 3 months of
CC       age.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the SMP-30/CGR1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X69021; CAA48786.1; -; mRNA.
DR   EMBL; D38467; BAA07490.1; -; mRNA.
DR   EMBL; AB037934; BAA90692.1; -; mRNA.
DR   EMBL; BC078794; AAH78794.1; -; mRNA.
DR   EMBL; D67070; BAA11083.1; -; Genomic_DNA.
DR   EMBL; D31662; BAA06507.1; -; Genomic_DNA.
DR   PIR; S34588; S34588.
DR   RefSeq; NP_113734.1; NM_031546.1.
DR   AlphaFoldDB; Q03336; -.
DR   SMR; Q03336; -.
DR   IntAct; Q03336; 2.
DR   STRING; 10116.ENSRNOP00000010984; -.
DR   iPTMnet; Q03336; -.
DR   PhosphoSitePlus; Q03336; -.
DR   PaxDb; Q03336; -.
DR   PRIDE; Q03336; -.
DR   Ensembl; ENSRNOT00000010984; ENSRNOP00000010984; ENSRNOG00000007949.
DR   GeneID; 25106; -.
DR   KEGG; rno:25106; -.
DR   UCSC; RGD:3560; rat.
DR   CTD; 9104; -.
DR   RGD; 3560; Rgn.
DR   eggNOG; KOG4499; Eukaryota.
DR   GeneTree; ENSGT00390000014995; -.
DR   HOGENOM; CLU_036110_3_2_1; -.
DR   InParanoid; Q03336; -.
DR   OMA; AGTMRYD; -.
DR   OrthoDB; 1343872at2759; -.
DR   PhylomeDB; Q03336; -.
DR   TreeFam; TF323663; -.
DR   BioCyc; MetaCyc:MON-13233; -.
DR   BRENDA; 3.1.8.2; 5301.
DR   UniPathway; UPA00991; UER00938.
DR   PRO; PR:Q03336; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000007949; Expressed in liver and 16 other tissues.
DR   Genevisible; Q03336; RN.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0030234; F:enzyme regulator activity; IEA:InterPro.
DR   GO; GO:0004341; F:gluconolactonase activity; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0019853; P:L-ascorbic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:1903011; P:negative regulation of bone development; IDA:RGD.
DR   GO; GO:1903611; P:negative regulation of calcium-dependent ATPase activity; IMP:RGD.
DR   GO; GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; IDA:RGD.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:1903625; P:negative regulation of DNA catabolic process; IDA:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:RGD.
DR   GO; GO:1901318; P:negative regulation of flagellated sperm motility; IDA:RGD.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IMP:RGD.
DR   GO; GO:1903634; P:negative regulation of leucine-tRNA ligase activity; IDA:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IMP:RGD.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IMP:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:1902679; P:negative regulation of RNA biosynthetic process; IMP:RGD.
DR   GO; GO:0032781; P:positive regulation of ATP-dependent activity; IDA:UniProtKB.
DR   GO; GO:1901896; P:positive regulation of ATPase-coupled calcium transmembrane transporter activity; IDA:RGD.
DR   GO; GO:1903629; P:positive regulation of dUTP diphosphatase activity; IDA:RGD.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; IDA:RGD.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; IDA:RGD.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:RGD.
DR   GO; GO:0010922; P:positive regulation of phosphatase activity; IMP:RGD.
DR   GO; GO:1903052; P:positive regulation of proteolysis involved in protein catabolic process; IDA:RGD.
DR   GO; GO:1901671; P:positive regulation of superoxide dismutase activity; IDA:RGD.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; IDA:RGD.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IDA:RGD.
DR   Gene3D; 2.120.10.30; -; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR008367; Regucalcin.
DR   InterPro; IPR013658; SGL.
DR   InterPro; IPR005511; SMP-30.
DR   Pfam; PF08450; SGL; 1.
DR   PRINTS; PR01791; REGUCALCIN.
DR   PRINTS; PR01790; SMP30FAMILY.
PE   1: Evidence at protein level;
KW   Ascorbate biosynthesis; Calcium; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Metal-binding; Phosphoprotein; Reference proteome.
FT   CHAIN           1..299
FT                   /note="Regucalcin"
FT                   /id="PRO_0000173049"
FT   ACT_SITE        204
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         18
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   BINDING         101
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         103
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         121
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         154
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   BINDING         204
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         144
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         244
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         253
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        148
FT                   /note="D -> N (in Ref. 2; BAA07490 and 6; BAA06507)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   299 AA;  33390 MW;  5D8F2D95FCA4EE35 CRC64;
     MSSIKIECVL RENYRCGESP VWEEASKCLL FVDIPSKTVC RWDSISNRVQ RVGVDAPVSS
     VALRQSGGYV ATIGTKFCAL NWEDQSVFIL AMVDEDKKNN RFNDGKVDPA GRYFAGTMAE
     ETAPAVLERH QGSLYSLFPD HSVKKYFDQV DISNGLDWSL DHKIFYYIDS LSYTVDAFDY
     DLPTGQISNR RTVYKMEKDE QIPDGMCIDV EGKLWVACYN GGRVIRLDPE TGKRLQTVKL
     PVDKTTSCCF GGKDYSEMYV TCARDGMSAE GLLRQPDAGN IFKITGLGVK GIAPYSYAG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024